Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001823197-25-000003
Filing Date
2025-10-14
Accepted
2025-10-14 12:22:17
Documents
1
Period of Report
2025-10-13

Document Format Files

Seq Description Document Type Size
1 form4-10142025_041014.html 4  
1 form4-10142025_041014.xml 4 3920
  Complete submission text file 0001823197-25-000003.txt   5669
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Issuer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CHINOOK THERAPEUTICS U.S., INC. 1600 FAIRVIEW AVE. E. SEATTLE WA 98102
Business Address
Glicklich Alan (Reporting) CIK: 0001823197 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39538 | Film No.: 251390826